JP2024544057A5 - - Google Patents
Info
- Publication number
- JP2024544057A5 JP2024544057A5 JP2024532197A JP2024532197A JP2024544057A5 JP 2024544057 A5 JP2024544057 A5 JP 2024544057A5 JP 2024532197 A JP2024532197 A JP 2024532197A JP 2024532197 A JP2024532197 A JP 2024532197A JP 2024544057 A5 JP2024544057 A5 JP 2024544057A5
- Authority
- JP
- Japan
- Prior art keywords
- fxi
- binding protein
- blood coagulation
- coagulation factor
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111439560 | 2021-11-30 | ||
| CN202111439560.3 | 2021-11-30 | ||
| PCT/CN2022/134868 WO2023098637A1 (zh) | 2021-11-30 | 2022-11-29 | 预防和/或治疗血栓栓塞性疾病的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544057A JP2024544057A (ja) | 2024-11-27 |
| JP2024544057A5 true JP2024544057A5 (https=) | 2025-12-03 |
Family
ID=86516220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532197A Pending JP2024544057A (ja) | 2021-11-30 | 2022-11-29 | 血栓塞栓性疾患を予防及び／又は治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250034277A1 (https=) |
| EP (1) | EP4442273A4 (https=) |
| JP (1) | JP2024544057A (https=) |
| CN (1) | CN116199782A (https=) |
| WO (1) | WO2023098637A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025237307A1 (zh) * | 2024-05-14 | 2025-11-20 | 苏州康宁杰瑞生物科技有限公司 | 凝血因子FXI/FXIa抑制剂用于治疗肺动脉高压和/或高血压 |
| WO2026032397A1 (en) * | 2024-08-09 | 2026-02-12 | Zai Lab (Shanghai) Co., Ltd. | Binding molecules with an interleukin-31 receptor subunit alpha-antigen-binding domain and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| CN102558355B (zh) | 2011-12-31 | 2015-02-25 | 苏州康宁杰瑞生物科技有限公司 | 基于电荷网络的异二聚体fc改造方法及异二聚体蛋白的制备方法 |
| CN102851338A (zh) | 2012-07-25 | 2013-01-02 | 苏州康宁杰瑞生物科技有限公司 | 利用电荷排斥作用制备同二聚体蛋白混合物的方法 |
| RU2757314C2 (ru) * | 2016-01-22 | 2021-10-13 | Мерк Шарп И Доум Корп. | Антитела против фактора свертывания xi |
| IL315266A (en) * | 2016-06-14 | 2024-10-01 | Merck Sharp ַ& Dohme Llc | Anti-coagulation factor xi antibodies |
| CN113880949A (zh) * | 2020-07-03 | 2022-01-04 | 苏州康宁杰瑞生物科技有限公司 | 凝血因子xi(fxi)结合蛋白 |
| CA3188566A1 (en) * | 2020-07-03 | 2022-01-06 | Suzhou Alphamab Co., Ltd. | Coagulation factor xi (fxi) binding protein |
| CN113880951A (zh) * | 2020-07-03 | 2022-01-04 | 苏州康宁杰瑞生物科技有限公司 | 凝血因子xi(fxi)结合蛋白 |
| CN113880950A (zh) * | 2020-07-03 | 2022-01-04 | 苏州康宁杰瑞生物科技有限公司 | 凝血因子xi(fxi)结合蛋白 |
-
2022
- 2022-11-29 EP EP22900441.1A patent/EP4442273A4/en active Pending
- 2022-11-29 WO PCT/CN2022/134868 patent/WO2023098637A1/zh not_active Ceased
- 2022-11-29 US US18/714,678 patent/US20250034277A1/en active Pending
- 2022-11-29 CN CN202211512928.9A patent/CN116199782A/zh active Pending
- 2022-11-29 JP JP2024532197A patent/JP2024544057A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2316852B1 (en) | Stabilized single domain antibodies | |
| US7052695B2 (en) | Angiopoietins and methods of treating hypertension | |
| ES2361917T3 (es) | Inhibidores del receptor 1 del factor de crecimiento de fibroblastos y procedimiento de tratamiento de los mismos. | |
| US20170107302A1 (en) | Stabilized single domain antibodies | |
| JP2023085476A5 (https=) | ||
| JP2024544057A5 (https=) | ||
| JP2025169389A5 (https=) | ||
| US20240368262A1 (en) | A myostatin pathway inhibitor in combination with a glp-1 pathway activator for use in treating metabolic disorders | |
| WO2004041865A2 (en) | Stabilized single domain antibodies | |
| RU2014106652A (ru) | Ингибирующие моноклональные антитела против фактора xii/xiia и их применения | |
| US20120039882A1 (en) | Vascular Disease Therapies | |
| IL263272B1 (en) | Antibodies to coagulation factor XI | |
| CN100377742C (zh) | 包含低分子量凝血酶抑制剂及其药物前体的药用制剂 | |
| JP2022512647A5 (https=) | ||
| JP2023530335A5 (https=) | ||
| JP2020535161A5 (https=) | ||
| JP2025518227A (ja) | ｍａｚｄｕｔｉｄｅを使用する治療方法 | |
| JP2024542777A5 (https=) | ||
| JP2024542823A5 (https=) | ||
| JP2024537284A5 (https=) | ||
| PT1737490E (pt) | Processos de tratamento da aterosclerose | |
| JP2023506779A5 (https=) | ||
| CN117547604A (zh) | 一种抗IL-1β的纳米体药物及其应用 | |
| IL316218A (en) | Preparations and methods for treating eye diseases | |
| JP2023544409A (ja) | 皮膚筋炎を治療する方法 |